InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (60 ops.)
Discover the detailed record of transactions filed by Susi Roger E., Founder, Chairman, Chief Executive Officer and President. Insider active across 1 companies, notably Iradimed CORP. Cumulatively, 62 disclosures have been recorded. Total volume traded: €17.6m. The latest transaction was disclosed on 3 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations62 total
€318,46610,000 shares@ €31.84660.029% mcap1.8% of flow
Common Stock
SEC:0000898432-22-000322:0·
€383,69710,000 shares@ €38.36970.035% mcap2.2% of flow
Common Stock
SEC:0000898432-22-000316:0·
€406,71110,000 shares@ €40.67110.037% mcap2.3% of flow
Common Stock
SEC:0000898432-22-000288:0·
€396,27410,000 shares@ €39.62740.036% mcap2.3% of flow
Common Stock
SEC:0000898432-22-000273:0·
€417,42910,000 shares@ €41.74290.038% mcap2.4% of flow
Common Stock
SEC:0000898432-22-000265:0·
€481,67510,000 shares@ €48.16750.044% mcap2.7% of flow
Common Stock
SEC:0000898432-22-000229:0·
€453,49610,000 shares@ €45.34960.041% mcap2.6% of flow
Common Stock
SEC:0000898432-22-000223:0·
€425,31810,000 shares@ €42.53180.038% mcap2.4% of flow
Common Stock
SEC:0000898432-22-000222:0·
€432,52710,000 shares@ €43.25270.039% mcap2.5% of flow
Common Stock
SEC:0000898432-22-000219:0·
€439,15610,000 shares@ €43.91560.040% mcap2.5% of flow
Common Stock
SEC:0000898432-22-000210:0·
€419,95510,000 shares@ €41.99550.038% mcap2.4% of flow
Common Stock
SEC:0000898432-22-000198:0·
€414,50110,000 shares@ €41.45010.038% mcap2.4% of flow
Common Stock
SEC:0000898432-22-000121:0·
€414,16710,000 shares@ €41.41670.037% mcap6.6% of flow
Common Stock
SEC:0000898432-22-000079·
€414,16710,000 shares@ €41.41670.037% mcap2.4% of flow
Common Stock
SEC:0000898432-22-000079:0·
€349,84810,000 shares@ €34.98480.032% mcap5.5% of flow
Common Stock
SEC:0000898432-22-000076·
€349,84810,000 shares@ €34.98480.032% mcap2.0% of flow
Common Stock
SEC:0000898432-22-000076:0·
€329,57510,000 shares@ €32.95750.030% mcap5.2% of flow
Common Stock
SEC:0000898432-22-000065·
€329,57510,000 shares@ €32.95750.030% mcap1.9% of flow
Common Stock
SEC:0000898432-22-000065:0·
€361,11810,000 shares@ €36.11180.033% mcap5.7% of flow
Common Stock
SEC:0000898432-22-000035·
€361,11810,000 shares@ €36.11180.033% mcap2.1% of flow
Common Stock
SEC:0000898432-22-000035:0·
€393,08310,000 shares@ €39.30830.036% mcap6.2% of flow
Common Stock
SEC:0000898432-22-000034·
€393,08310,000 shares@ €39.30830.036% mcap2.2% of flow
Common Stock
SEC:0000898432-22-000034:0·
022,600 shares0
Common Stock
SEC:0000898432-22-000014·
€429,67510,000 shares@ €42.96750.039% mcap6.8% of flow
Common Stock
SEC:0000898432-22-000015·
022,600 shares0
Common Stock
SEC:0000898432-22-000014:0·
25 of 62 declarations
About Susi Roger E.
Roger E. Susi is an American biomedical engineer and healthcare executive best known for his long-standing leadership at IRadimed Corporation, a NASDAQ-listed medical device company focused on MRI-compatible monitoring and infusion solutions. He is currently identified by IRadimed as the company’s founder, President, and Chief Executive Officer, and he has served on the board since the company’s inception. According to company filings and corporate materials, he served as President and CEO from inception until August 2019, then moved into the Chief Technology Officer role for a period, before resuming his duties as President and CEO in May 2020. His career in the medical device industry spans more than four decades, giving him deep experience in hospital technology, product development, and MRI safety applications. Before IRadimed, Susi founded Invivo Research Inc., the predecessor to Invivo Corporation, where he served as founder, Chairman, and CEO, and later as a director of Invivo Corporation. That earlier chapter established his reputation in MRI-safe patient monitoring and helped shape one of the core technical areas of his later career. IRadimed credits him with pioneering major innovations in MRI patient monitoring and with helping develop the company’s non-magnetic infusion pumps and patient monitoring systems. These achievements are central to his executive profile because they link leadership with hands-on technical innovation in a highly specialized medical niche. Susi earned a B.S. in Biomedical Engineering from Case Western Reserve University. His professional profile combines engineering expertise, entrepreneurial company-building, and long-term operational leadership. Notable career themes include founding and scaling specialized medical technology businesses, advancing MRI-compatible product platforms, and guiding strategic continuity across multiple phases of corporate growth. For corporate governance and executive SEO purposes, his most notable recent role is that of Founder, Chairman, President, and Chief Executive Officer of IRadimed Corporation, reflecting both his governance presence and his operational authority within the company.
